TME(TME)
TME
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E |
|---|---|---|---|---|
| Revenue Avg | $35.57B | $38.85B | $42.10B | $41.74B |
| Low | $34.61B | $37.59B | $40.26B | $39.92B |
| High | $36.32B | $42.88B | $45.05B | $44.67B |
| EBITDA Avg | $9.62B | $10.50B | $11.38B | $11.29B |
| Low | $9.36B | $10.16B | $10.89B | $10.79B |
| High | $9.82B | $11.60B | $12.18B | $12.08B |
| EBIT Avg | $8.37B | $9.14B | $9.91B | $9.83B |
| Low | $8.15B | $8.85B | $9.48B | $9.40B |
| High | $8.55B | $10.09B | $10.61B | $10.52B |
| Net Income Avg | $9.32B | $10.34B | $13.54B | $12.04B |
| Low | $8.98B | $10.09B | $9.95B | $11.35B |
| High | $9.66B | $10.59B | $17.13B | $13.14B |
| EPS Avg | $6.09 | $6.68 | $7.62 | $7.74 |
| Low | $5.78 | $6.49 | $6.40 | $7.30 |
| High | $6.21 | $6.81 | $11.02 | $8.45 |
| Analysts (Rev / EPS) | 19 / 12 | 19 / 13 | 21 / 12 | 10 / 10 |
| Metric | Q2 2026 | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $8.78B | $9.12B | $9.31B | $8.57B | $9.84B | $9.75B | $9.88B | $9.26B |
| Low | $8.65B | $8.98B | $9.11B | $8.39B | $9.63B | $9.54B | $9.66B | $9.06B |
| High | $8.99B | $9.19B | $9.60B | $8.84B | $10.15B | $10.06B | $10.19B | $9.55B |
| EBITDA Avg | $2.38B | $2.47B | $2.52B | $2.32B | $2.66B | $2.64B | $2.67B | $2.50B |
| Low | $2.34B | $2.43B | $2.46B | $2.27B | $2.60B | $2.58B | $2.61B | $2.45B |
| High | $2.43B | $2.48B | $2.60B | $2.39B | $2.75B | $2.72B | $2.76B | $2.58B |
| EBIT Avg | $2.07B | $2.15B | $2.19B | $2.02B | $2.32B | $2.30B | $2.32B | $2.18B |
| Low | $2.04B | $2.11B | $2.14B | $1.97B | $2.27B | $2.25B | $2.27B | $2.13B |
| High | $2.12B | $2.16B | $2.26B | $2.08B | $2.39B | $2.37B | $2.40B | $2.25B |
| Net Income Avg | $2.43B | $2.38B | $2.58B | $2.51B | $2.82B | $2.87B | $2.43B | $2.54B |
| Low | $2.36B | $2.31B | $2.50B | $2.44B | $2.74B | $2.79B | $2.36B | $2.47B |
| High | $2.53B | $2.48B | $2.68B | $2.62B | $2.94B | $2.99B | $2.53B | $2.65B |
| EPS Avg | $1.56 | $1.53 | $1.66 | $1.62 | $1.81 | $1.85 | $1.56 | $1.63 |
| Low | $1.52 | $1.49 | $1.61 | $1.57 | $1.76 | $1.80 | $1.52 | $1.59 |
| High | $1.63 | $1.59 | $1.72 | $1.68 | $1.89 | $1.92 | $1.63 | $1.70 |
| Analysts (Rev / EPS) | 6 / 4 | 5 / 4 | 2 / 2 | 2 / 2 | 2 / 1 | 2 / 1 | 2 / 2 | 1 / 3 |